Rosanna Zhang

Rosanna Zhang

Vice President of Strategy & Corporate Development, ACROBiosystems

Rosanna leads global M&A, BD&L, and strategic partnerships at ACROBiosystems (SZSE: 301080), driving innovation in neurobiology and organoid technologies. With origins in recombinant proteins, ACRO now supplies critical reagents for biologics and cell therapy development, serving 10,000+ biopharma clients across 80+ countries through 10+ global offices.
Trained at MIT (BS) and Harvard/MGH, her stem cell research on neurodegenerative diseases (e.g., ALS) was published in Nature Nanotechnology and Nature Communications. A serial entrepreneur, she co-founded MedTech firm NeuShen Therapeutics, advancing neuromodulation devices for depression/cognitive disorders, and launched a cross-border VC fund investing in 20+ biotech pioneers.

Presentation(s):

• APPLICATIONS AND PROSPECTS OF ORGANOID TECHNOLOGY IN DRUG SCREENING AND TOXICOLOGY TESTING

  Wednesday, June 11, 2025
  1:00 PM - 1:30 PM HK Time